跳至主要内容
临床试验/IRCT20190303042905N3
IRCT20190303042905N3招募中2 期

The Effects of butyrate supplementation on plasma atherogenic index(AIP), serum level of hsCRP, expression level of adiponectin receptors(AdipoR1& R2), AMP activated protein kinase(AMPK) and uncoupling proteins(UCP2&3) genes in Obese individuals on a weight loss diet: A Randomized, Triple- Blind, Placebo- Controlled Clinical Trial

Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Body mass index (BMI) between 30-40
  • Both of genders female and male
  • Age between 18-60 years old

排除标准

  • Unwillingness to participate in the study
  • Kidney diseases
  • liver failure
  • heart failure
  • rheumatic diseases
  • malignancies, and gastrointestinal diseases
  • Taking weightloss drugs and following a weight loss diet
  • History of bariatric surgery
  • Pregnancy, lactation, menopause

研究者

相似试验

The Effects of sodium butyrate supplementation on... | 临床试验